- Home
- PPBI vs CNTA Comparison
PPBI vs CNTA Comparison
Compare PPBI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBI
- CNTA
- Stock Information
- Founded
- PPBI 1983
- CNTA 2020
- Country
- PPBI United States
- CNTA United Kingdom
- Employees
- PPBI N/A
- CNTA N/A
- Industry
- PPBI Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- PPBI Finance
- CNTA Health Care
- Exchange
- PPBI Nasdaq
- CNTA Nasdaq
- Market Cap
- PPBI N/A
- CNTA 1.6B
- IPO Year
- PPBI 1997
- CNTA 2021
- Fundamental
- Price
- PPBI $22.36
- CNTA $14.29
- Analyst Decision
- PPBI Buy
- CNTA Strong Buy
- Analyst Count
- PPBI 4
- CNTA 10
- Target Price
- PPBI $27.25
- CNTA $28.78
- AVG Volume (30 Days)
- PPBI 1.0M
- CNTA 992.4K
- Earning Date
- PPBI 07-23-2025
- CNTA 08-12-2025
- Dividend Yield
- PPBI 5.78%
- CNTA N/A
- EPS Growth
- PPBI 984.39
- CNTA N/A
- EPS
- PPBI 1.53
- CNTA N/A
- Revenue
- PPBI $591,231,000.00
- CNTA $15,000,000.00
- Revenue This Year
- PPBI N/A
- CNTA N/A
- Revenue Next Year
- PPBI $6.74
- CNTA N/A
- P/E Ratio
- PPBI $14.61
- CNTA N/A
- Revenue Growth
- PPBI 40.61
- CNTA 118.88
- 52 Week Low
- PPBI $18.06
- CNTA $9.00
- 52 Week High
- PPBI $30.28
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- PPBI 57.10
- CNTA 61.38
- Support Level
- PPBI $20.93
- CNTA $13.22
- Resistance Level
- PPBI $23.30
- CNTA $14.74
- Average True Range (ATR)
- PPBI 0.53
- CNTA 0.73
- MACD
- PPBI 0.14
- CNTA 0.14
- Stochastic Oscillator
- PPBI 69.38
- CNTA 85.11
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.